查看购物车
  • Traditional Chinese
  • English
  • Japanese
  • Korean
封面
市场调查报告书
商品编码
1279668

2022-2029年全球人工智能在糖尿病管理中的市场规模研究和预测，按类型、按应用和区域分析

Global Artificial Intelligence in Diabetes Management Market Size study & Forecast, by Type, by Application and Regional Analysis, 2022-2029
出版日期: | 出版商: Bizwit Research & Consulting LLP | 英文 | 商品交期: 2-3个工作天内

价格

糖尿病管理中的人工智能（AI）指的是使用先进的计算技术，如机器学习算法，来协助管理和治疗糖尿病。糖尿病管理中的人工智能的目标是帮助患者更有效地监测和管理他们的血糖水平，减少并发症的风险，并提高他们的整体生活质量。全球糖尿病管理中的人工智能（AI）市场的主要驱动因素是糖尿病发病率的增长、人工智能和机器学习的进步以及对个性化医疗的需求增加。此外，可穿戴设备的采用越来越多，人工智能和机器学习的进步越来越大，在2022-2029年的预测期内，正在为市场创造有利可图的增长机会。

在非洲，国际糖尿病联合会（IDF）估计，2019年有1940万糖尿病患者，预计到2045年，这一数字将上升到4700万。(来源：IDF糖尿病地图，第9版，2019年）。同样，在东南亚，IDF估计2019年有8800万糖尿病患者，到2045年这一数字预计将上升到1.53亿。(资料来源：IDF糖尿病地图，第九版，2019年）。与此同时，在西太平洋地区，IDF估计2019年有1.59亿糖尿病患者，到2045年这一数字预计将上升到2.14亿。(资料来源：IDF糖尿病地图，第九版，2019年）。然而，在2022-2029年的整个预测期间，糖尿病管理中的人工智能（AI）的高成本扼杀了市场增长。

全球糖尿病管理中的人工智能（AI）市场研究考虑的主要地区包括亚太、北美、欧洲、拉美和世界其他地区。北美市场是糖尿病管理中人工智能的最大市场，主要是受该地区糖尿病的高发病率、先进的医疗基础设施的可用性以及数字技术的采用所驱动。美国是北美最大的市场，其次是加拿大。亚太地区的糖尿病管理人工智能市场预计将大幅增长，其驱动因素包括糖尿病的高发病率、医疗支出的增加以及数字技术的日益采用。中国、印度和日本是亚太地区的主要市场。

该研究的目的是确定近年来不同细分市场和国家的市场规模，并对未来几年的价值进行预测。该报告旨在将研究涉及的国家内的行业的质量和数量方面都纳入其中。

该报告还提供了关于关键方面的详细信息，如驱动因素和挑战，这将确定市场的未来增长。此外，它还纳入了微观市场的潜在机会，供利益相关者投资，并详细分析了竞争格局和主要参与者的产品。.

目录

第一章：执行摘要

  • 市场简介
  • 2019-2029年全球和细分市场的估计和预测
    • 糖尿病管理中的人工智能（AI）市场，按地区划分，2019-2029年
    • 糖尿病管理中的人工智能（AI）市场，按类型划分，2019-2029年
    • 糖尿病管理中的人工智能（AI）市场，按应用，2019-2029年
  • 主要趋势
  • 估算方法
  • 研究假设

第二章：全球糖尿病管理中的人工智能（AI）市场的定义和范围

  • 本研究的目的
  • 市场定义和范围
    • 研究的范围
    • 行业演变
  • 研究考虑的年份
  • 货币兑换率

第三章：全球糖尿病管理中的人工智能（AI）市场动态

  • 糖尿病管理中的人工智能（AI）市场影响分析（2019-2029）。
    • 市场驱动力
      • 糖尿病的发病率不断上升
      • 人工智能和机器学习的进步
      • 对个性化医疗的需求不断增加
    • 市场挑战
      • 糖尿病管理中的人工智能（AI）成本高
    • 市场机会
      • 可穿戴设备的采用越来越多
      • 人工智能和机器学习的进步

第四章：全球糖尿病管理中的人工智能（AI）市场行业分析

  • 波特的5力模型
    • 供应商的讨价还价能力
    • 买方的讨价还价能力
    • 新进入者的威胁
    • 替代品的威胁
    • 竞争性的竞争
  • 波特五力模型的未来方法（2019-2029年）
  • PEST分析
    • 政治因素
    • 经济
    • 社会
    • 技术
  • 投资采用模式
  • 分析师建议和结论
  • 最佳投资机会
  • 最佳策略

第五章：风险评估：COVID-19的影响

  • 评估COVID-19对行业的整体影响
  • COVID-19前和COVID-19后的市场情况

第六章：全球糖尿病管理中的人工智能（AI）市场，按类型划分

  • 市场简介
  • 全球糖尿病管理中的人工智能（AI）市场，按类型、性能 - 潜力分析
  • 2019-2029年全球糖尿病管理中的人工智能（AI）市场按类型估计和预测
  • 糖尿病管理中的人工智能（AI）市场，分项分析
    • 基于案例的推理
    • 智能数据分析

第七章 ：全球糖尿病管理中的人工智能（AI）市场，按应用分类

  • 市场简介
  • 全球糖尿病管理中的人工智能（AI）市场，按应用，性能 - 潜力分析
  • 2019-2029年全球糖尿病管理中的人工智能（AI）市场按应用估计和预测
  • 糖尿病管理中的人工智能（AI）市场，分项分析
    • 葡萄糖监测设备
    • 诊断设备
    • 胰岛素输送设备
    • 其他设备

第八章：全球糖尿病管理中的人工智能（AI）市场，区域分析

  • 糖尿病管理中的人工智能（AI）市场，区域市场简介
  • 北美洲
    • 美国
      • 类型细分估计和预测，2019-2029年
      • 应用分类估计和预测，2019-2029年
    • 加拿大
  • 欧洲糖尿病管理中的人工智能（AI）市场简介
    • 英国
    • 德国
    • 法国
    • 西班牙
    • 意大利
    • 欧洲其他地区
  • 亚太地区糖尿病管理中的人工智能（AI）市场简介
    • 中国
    • 印度
    • 日本
    • 澳大利亚
    • 韩国
    • 亚太其他地区
  • 拉美糖尿病管理中的人工智能（AI）市场简介
    • 巴西
    • 墨西哥
  • 世界其他地区

第九章：竞争情报

  • 顶级市场战略
  • 公司简介
    • Abbott Laboratories
      • 关键信息
      • 概况
      • 财务（取决于数据的可用性）
      • 产品摘要
      • 近期发展情况
    • Medtronic
    • Dexcom
    • Glooko
    • Diabeloop
    • Bigfoot Biomedical
    • Beta Bionics
    • One Drop
    • Diabnext
    • Tidepool

第十章 ：研究过程

  • 研究过程
    • 资料探勘
    • 数据分析
    • 市场评估
    • 验证
    • 出版
  • 研究属性
  • 研究假设

Global Artificial Intelligence (AI) in Diabetes Management Market is valued approximately USD XX billion in 2021 and is anticipated to grow with a healthy growth rate of more than XX% over the forecast period 2022-2029. Artificial Intelligence (AI) in diabetes management refers to the use of advanced computing technologies, such as machine learning algorithms, to assist in the management and treatment of diabetes. The goal of AI in diabetes management is to help patients monitor and manage their blood sugar levels more effectively, reduce the risk of complications, and improve their overall quality of life. The major driving factors for the Global Artificial Intelligence (AI) in Diabetes Management Market are growing prevalence of diabetes, advancements in AI and machine learning and increasing demand for personalized healthcare. Moreover, growing adoption of wearable devices and rising advancements in AI and machine learning is creating lucrative growth opportunity for the market over the forecast period 2022-2029.

In Africa, the International Diabetes Federation (IDF) estimates that there were 19.4 million people with diabetes in 2019, and this number is expected to rise to 47 million by 2045. (Source: IDF Diabetes Atlas, 9th edition, 2019). Similarly, in South-East Asia, the IDF estimates that there were 88 million people with diabetes in 2019, and this number is expected to rise to 153 million by 2045. (Source: IDF Diabetes Atlas, 9th edition, 2019). Along with this, in the Western Pacific region, the IDF estimates that there were 159 million people with diabetes in 2019, and this number is expected to rise to 214 million by 2045. (Source: IDF Diabetes Atlas, 9th edition, 2019). However, the high cost of Artificial Intelligence (AI) in Diabetes Management stifles market growth throughout the forecast period of 2022-2029.

The key regions considered for the Global Artificial Intelligence (AI) in Diabetes Management Market study includes Asia Pacific, North America, Europe, Latin America, and Rest of the World. The North American market is the largest market for AI in diabetes management, primarily driven by the high prevalence of diabetes in the region, the availability of advanced healthcare infrastructure, and the adoption of digital technologies. The US is the largest market in North America, followed by Canada. The Asia Pacific market for AI in diabetes management is expected to grow at a significant rate, driven by factors such as the high prevalence of diabetes, increasing healthcare expenditure, and growing adoption of digital technologies. China, India, and Japan are the major markets in the Asia Pacific region.

Major market players included in this report are:

  • Abbott Laboratories
  • Medtronic
  • Dexcom
  • Glooko
  • Diabeloop
  • Bigfoot Biomedical
  • Beta Bionics
  • One Drop
  • Diabnext
  • Tidepool

Recent Developments in the Market:

  • In May 2021, Abbott Laboratories announced that it had received FDA clearance for its AI-powered algorithm, which is designed to help people with diabetes better manage their glucose levels using the FreeStyle Libre 2 CGM system.
  • In February 2021, Medtronic announced that it had received CE Mark approval for its AI-powered predictive insulin dosing algorithm, which is designed to help people with diabetes avoid hypoglycemia.
  • In January 2021, Dexcom announced that it had acquired TypeZero Technologies, a company that develops AI-powered diabetes management solutions, to enhance its product offerings in the AI diabetes management space.
  • In December 2020, Glooko announced that it had received FDA clearance for its AI-powered insulin titration solution, which is designed to help healthcare providers adjust insulin doses for people with diabetes more efficiently.

Global Artificial Intelligence (AI) in Diabetes Management Market Report Scope:

  • Historical Data: 2019-2020-2021
  • Base Year for Estimation: 2021
  • Forecast period: 2022-2029
  • Report Coverage: Revenue forecast, Company Ranking, Competitive Landscape, Growth factors, and Trends
  • Segments Covered: Application, Type, Region
  • Regional Scope: North America; Europe; Asia Pacific; Latin America; Rest of the World
  • Customization Scope: Free report customization (equivalent up to 8 analyst's working hours) with purchase. Addition or alteration to country, regional & segment scope*

The objective of the study is to define market sizes of different segments & countries in recent years and to forecast the values to the coming years. The report is designed to incorporate both qualitative and quantitative aspects of the industry within countries involved in the study.

The report also caters detailed information about the crucial aspects such as driving factors & challenges which will define the future growth of the market. Additionally, it also incorporates potential opportunities in micro markets for stakeholders to invest along with the detailed analysis of competitive landscape and product offerings of key players. The detailed segments and sub-segment of the market are explained below.

By Type:

  • Case-based Reasoning
  • Intelligent Data Analysis

By Application:

  • Glucose Monitoring Devices
  • Diagnostic Devices
  • Insulin Delivery Devices
  • Other Devices

By Region:

  • North America
  • U.S.
  • Canada
  • Europe
  • UK
  • Germany
  • France
  • Spain
  • Italy
  • ROE
  • Asia Pacific
  • China
  • India
  • Japan
  • Australia
  • South Korea
  • RoAPAC
  • Latin America
  • Brazil
  • Mexico
  • Rest of the World

Table of Contents

Chapter 1. Executive Summary

  • 1.1. Market Snapshot
  • 1.2. Global & Segmental Market Estimates & Forecasts, 2019-2029 (USD Billion)
    • 1.2.1. Artificial Intelligence (AI) in Diabetes Management Market, by Region, 2019-2029 (USD Billion)
    • 1.2.2. Artificial Intelligence (AI) in Diabetes Management Market, by Type, 2019-2029 (USD Billion)
    • 1.2.3. Artificial Intelligence (AI) in Diabetes Management Market, by Application, 2019-2029 (USD Billion)
  • 1.3. Key Trends
  • 1.4. Estimation Methodology
  • 1.5. Research Assumption

Chapter 2. Global Artificial Intelligence (AI) in Diabetes Management Market Definition and Scope

  • 2.1. Objective of the Study
  • 2.2. Market Definition & Scope
    • 2.2.1. Scope of the Study
    • 2.2.2. Industry Evolution
  • 2.3. Years Considered for the Study
  • 2.4. Currency Conversion Rates

Chapter 3. Global Artificial Intelligence (AI) in Diabetes Management Market Dynamics

  • 3.1. Artificial Intelligence (AI) in Diabetes Management Market Impact Analysis (2019-2029)
    • 3.1.1. Market Drivers
      • 3.1.1.1. Growing prevalence of diabetes
      • 3.1.1.2. Advancements in AI and machine learning
      • 3.1.1.3. Increasing demand for personalized healthcare
    • 3.1.2. Market Challenges
      • 3.1.2.1. High cost of Artificial Intelligence (AI) in Diabetes Management
    • 3.1.3. Market Opportunities
      • 3.1.3.1. Growing adoption of wearable devices
      • 3.1.3.2. Advancements in AI and machine learning

Chapter 4. Global Artificial Intelligence (AI) in Diabetes Management Market Industry Analysis

  • 4.1. Porter's 5 Force Model
    • 4.1.1. Bargaining Power of Suppliers
    • 4.1.2. Bargaining Power of Buyers
    • 4.1.3. Threat of New Entrants
    • 4.1.4. Threat of Substitutes
    • 4.1.5. Competitive Rivalry
  • 4.2. Futuristic Approach to Porter's 5 Force Model (2019-2029)
  • 4.3. PEST Analysis
    • 4.3.1. Political
    • 4.3.2. Economical
    • 4.3.3. Social
    • 4.3.4. Technological
  • 4.4. Investment Adoption Model
  • 4.5. Analyst Recommendation & Conclusion
  • 4.6. Top investment opportunity
  • 4.7. Top winning strategies

Chapter 5. Risk Assessment: COVID-19 Impact

  • 5.1. Assessment of the overall impact of COVID-19 on the industry
  • 5.2. Pre COVID-19 and post COVID-19 Market scenario

Chapter 6. Global Artificial Intelligence (AI) in Diabetes Management Market, by Type

  • 6.1. Market Snapshot
  • 6.2. Global Artificial Intelligence (AI) in Diabetes Management Market by Type, Performance - Potential Analysis
  • 6.3. Global Artificial Intelligence (AI) in Diabetes Management Market Estimates & Forecasts by Type 2019-2029 (USD Billion)
  • 6.4. Artificial Intelligence (AI) in Diabetes Management Market, Sub Segment Analysis
    • 6.4.1. Case-based Reasoning
    • 6.4.2. Intelligent Data Analysis

Chapter 7. Global Artificial Intelligence (AI) in Diabetes Management Market, by Application

  • 7.1. Market Snapshot
  • 7.2. Global Artificial Intelligence (AI) in Diabetes Management Market by Application, Performance - Potential Analysis
  • 7.3. Global Artificial Intelligence (AI) in Diabetes Management Market Estimates & Forecasts by Application 2019-2029 (USD Billion)
  • 7.4. Artificial Intelligence (AI) in Diabetes Management Market, Sub Segment Analysis
    • 7.4.1. Glucose Monitoring Devices
    • 7.4.2. Diagnostic Devices
    • 7.4.3. Insulin Delivery Devices
    • 7.4.4. Other Devices

Chapter 8. Global Artificial Intelligence (AI) in Diabetes Management Market, Regional Analysis

  • 8.1. Artificial Intelligence (AI) in Diabetes Management Market, Regional Market Snapshot
  • 8.2. North America Artificial Intelligence (AI) in Diabetes Management Market
    • 8.2.1. U.S. Artificial Intelligence (AI) in Diabetes Management Market
      • 8.2.1.1. Type breakdown estimates & forecasts, 2019-2029
      • 8.2.1.2. Application breakdown estimates & forecasts, 2019-2029
    • 8.2.2. Canada Artificial Intelligence (AI) in Diabetes Management Market
  • 8.3. Europe Artificial Intelligence (AI) in Diabetes Management Market Snapshot
    • 8.3.1. U.K. Artificial Intelligence (AI) in Diabetes Management Market
    • 8.3.2. Germany Artificial Intelligence (AI) in Diabetes Management Market
    • 8.3.3. France Artificial Intelligence (AI) in Diabetes Management Market
    • 8.3.4. Spain Artificial Intelligence (AI) in Diabetes Management Market
    • 8.3.5. Italy Artificial Intelligence (AI) in Diabetes Management Market
    • 8.3.6. Rest of Europe Artificial Intelligence (AI) in Diabetes Management Market
  • 8.4. Asia-Pacific Artificial Intelligence (AI) in Diabetes Management Market Snapshot
    • 8.4.1. China Artificial Intelligence (AI) in Diabetes Management Market
    • 8.4.2. India Artificial Intelligence (AI) in Diabetes Management Market
    • 8.4.3. Japan Artificial Intelligence (AI) in Diabetes Management Market
    • 8.4.4. Australia Artificial Intelligence (AI) in Diabetes Management Market
    • 8.4.5. South Korea Artificial Intelligence (AI) in Diabetes Management Market
    • 8.4.6. Rest of Asia Pacific Artificial Intelligence (AI) in Diabetes Management Market
  • 8.5. Latin America Artificial Intelligence (AI) in Diabetes Management Market Snapshot
    • 8.5.1. Brazil Artificial Intelligence (AI) in Diabetes Management Market
    • 8.5.2. Mexico Artificial Intelligence (AI) in Diabetes Management Market
  • 8.6. Rest of The World Artificial Intelligence (AI) in Diabetes Management Market

Chapter 9. Competitive Intelligence

  • 9.1. Top Market Strategies
  • 9.2. Company Profiles
    • 9.2.1. Abbott Laboratories
      • 9.2.1.1. Key Information
      • 9.2.1.2. Overview
      • 9.2.1.3. Financial (Subject to Data Availability)
      • 9.2.1.4. Product Summary
      • 9.2.1.5. Recent Developments
    • 9.2.2. Medtronic
    • 9.2.3. Dexcom
    • 9.2.4. Glooko
    • 9.2.5. Diabeloop
    • 9.2.6. Bigfoot Biomedical
    • 9.2.7. Beta Bionics
    • 9.2.8. One Drop
    • 9.2.9. Diabnext
    • 9.2.10. Tidepool

Chapter 10. Research Process

  • 10.1. Research Process
    • 10.1.1. Data Mining
    • 10.1.2. Analysis
    • 10.1.3. Market Estimation
    • 10.1.4. Validation
    • 10.1.5. Publishing
  • 10.2. Research Attributes
  • 10.3. Research Assumption

LIST OF TABLES

  • TABLE 1. Global Artificial Intelligence (AI) in Diabetes Management Market, report scope
  • TABLE 2. Global Artificial Intelligence (AI) in Diabetes Management Market estimates & forecasts by Region 2019-2029 (USD Billion)
  • TABLE 3. Global Artificial Intelligence (AI) in Diabetes Management Market estimates & forecasts by Type 2019-2029 (USD Billion)
  • TABLE 4. Global Artificial Intelligence (AI) in Diabetes Management Market estimates & forecasts by Application 2019-2029 (USD Billion)
  • TABLE 5. Global Artificial Intelligence (AI) in Diabetes Management Market by segment, estimates & forecasts, 2019-2029 (USD Billion)
  • TABLE 6. Global Artificial Intelligence (AI) in Diabetes Management Market by region, estimates & forecasts, 2019-2029 (USD Billion)
  • TABLE 7. Global Artificial Intelligence (AI) in Diabetes Management Market by segment, estimates & forecasts, 2019-2029 (USD Billion)
  • TABLE 8. Global Artificial Intelligence (AI) in Diabetes Management Market by region, estimates & forecasts, 2019-2029 (USD Billion)
  • TABLE 9. Global Artificial Intelligence (AI) in Diabetes Management Market by segment, estimates & forecasts, 2019-2029 (USD Billion)
  • TABLE 10. Global Artificial Intelligence (AI) in Diabetes Management Market by region, estimates & forecasts, 2019-2029 (USD Billion)
  • TABLE 11. Global Artificial Intelligence (AI) in Diabetes Management Market by segment, estimates & forecasts, 2019-2029 (USD Billion)
  • TABLE 12. Global Artificial Intelligence (AI) in Diabetes Management Market by region, estimates & forecasts, 2019-2029 (USD Billion)
  • TABLE 13. Global Artificial Intelligence (AI) in Diabetes Management Market by segment, estimates & forecasts, 2019-2029 (USD Billion)
  • TABLE 14. Global Artificial Intelligence (AI) in Diabetes Management Market by region, estimates & forecasts, 2019-2029 (USD Billion)
  • TABLE 15. U.S. Artificial Intelligence (AI) in Diabetes Management Market estimates & forecasts, 2019-2029 (USD Billion)
  • TABLE 16. U.S. Artificial Intelligence (AI) in Diabetes Management Market estimates & forecasts by segment 2019-2029 (USD Billion)
  • TABLE 17. U.S. Artificial Intelligence (AI) in Diabetes Management Market estimates & forecasts by segment 2019-2029 (USD Billion)
  • TABLE 18. Canada Artificial Intelligence (AI) in Diabetes Management Market estimates & forecasts, 2019-2029 (USD Billion)
  • TABLE 19. Canada Artificial Intelligence (AI) in Diabetes Management Market estimates & forecasts by segment 2019-2029 (USD Billion)
  • TABLE 20. Canada Artificial Intelligence (AI) in Diabetes Management Market estimates & forecasts by segment 2019-2029 (USD Billion)
  • TABLE 21. UK Artificial Intelligence (AI) in Diabetes Management Market estimates & forecasts, 2019-2029 (USD Billion)
  • TABLE 22. UK Artificial Intelligence (AI) in Diabetes Management Market estimates & forecasts by segment 2019-2029 (USD Billion)
  • TABLE 23. UK Artificial Intelligence (AI) in Diabetes Management Market estimates & forecasts by segment 2019-2029 (USD Billion)
  • TABLE 24. Germany Artificial Intelligence (AI) in Diabetes Management Market estimates & forecasts, 2019-2029 (USD Billion)
  • TABLE 25. Germany Artificial Intelligence (AI) in Diabetes Management Market estimates & forecasts by segment 2019-2029 (USD Billion)
  • TABLE 26. Germany Artificial Intelligence (AI) in Diabetes Management Market estimates & forecasts by segment 2019-2029 (USD Billion)
  • TABLE 27. France Artificial Intelligence (AI) in Diabetes Management Market estimates & forecasts, 2019-2029 (USD Billion)
  • TABLE 28. France Artificial Intelligence (AI) in Diabetes Management Market estimates & forecasts by segment 2019-2029 (USD Billion)
  • TABLE 29. France Artificial Intelligence (AI) in Diabetes Management Market estimates & forecasts by segment 2019-2029 (USD Billion)
  • TABLE 30. Italy Artificial Intelligence (AI) in Diabetes Management Market estimates & forecasts, 2019-2029 (USD Billion)
  • TABLE 31. Italy Artificial Intelligence (AI) in Diabetes Management Market estimates & forecasts by segment 2019-2029 (USD Billion)
  • TABLE 32. Italy Artificial Intelligence (AI) in Diabetes Management Market estimates & forecasts by segment 2019-2029 (USD Billion)
  • TABLE 33. Spain Artificial Intelligence (AI) in Diabetes Management Market estimates & forecasts, 2019-2029 (USD Billion)
  • TABLE 34. Spain Artificial Intelligence (AI) in Diabetes Management Market estimates & forecasts by segment 2019-2029 (USD Billion)
  • TABLE 35. Spain Artificial Intelligence (AI) in Diabetes Management Market estimates & forecasts by segment 2019-2029 (USD Billion)
  • TABLE 36. RoE Artificial Intelligence (AI) in Diabetes Management Market estimates & forecasts, 2019-2029 (USD Billion)
  • TABLE 37. RoE Artificial Intelligence (AI) in Diabetes Management Market estimates & forecasts by segment 2019-2029 (USD Billion)
  • TABLE 38. RoE Artificial Intelligence (AI) in Diabetes Management Market estimates & forecasts by segment 2019-2029 (USD Billion)
  • TABLE 39. China Artificial Intelligence (AI) in Diabetes Management Market estimates & forecasts, 2019-2029 (USD Billion)
  • TABLE 40. China Artificial Intelligence (AI) in Diabetes Management Market estimates & forecasts by segment 2019-2029 (USD Billion)
  • TABLE 41. China Artificial Intelligence (AI) in Diabetes Management Market estimates & forecasts by segment 2019-2029 (USD Billion)
  • TABLE 42. India Artificial Intelligence (AI) in Diabetes Management Market estimates & forecasts, 2019-2029 (USD Billion)
  • TABLE 43. India Artificial Intelligence (AI) in Diabetes Management Market estimates & forecasts by segment 2019-2029 (USD Billion)
  • TABLE 44. India Artificial Intelligence (AI) in Diabetes Management Market estimates & forecasts by segment 2019-2029 (USD Billion)
  • TABLE 45. Japan Artificial Intelligence (AI) in Diabetes Management Market estimates & forecasts, 2019-2029 (USD Billion)
  • TABLE 46. Japan Artificial Intelligence (AI) in Diabetes Management Market estimates & forecasts by segment 2019-2029 (USD Billion)
  • TABLE 47. Japan Artificial Intelligence (AI) in Diabetes Management Market estimates & forecasts by segment 2019-2029 (USD Billion)
  • TABLE 48. South Korea Artificial Intelligence (AI) in Diabetes Management Market estimates & forecasts, 2019-2029 (USD Billion)
  • TABLE 49. South Korea Artificial Intelligence (AI) in Diabetes Management Market estimates & forecasts by segment 2019-2029 (USD Billion)
  • TABLE 50. South Korea Artificial Intelligence (AI) in Diabetes Management Market estimates & forecasts by segment 2019-2029 (USD Billion)
  • TABLE 51. Australia Artificial Intelligence (AI) in Diabetes Management Market estimates & forecasts, 2019-2029 (USD Billion)
  • TABLE 52. Australia Artificial Intelligence (AI) in Diabetes Management Market estimates & forecasts by segment 2019-2029 (USD Billion)
  • TABLE 53. Australia Artificial Intelligence (AI) in Diabetes Management Market estimates & forecasts by segment 2019-2029 (USD Billion)
  • TABLE 54. RoAPAC Artificial Intelligence (AI) in Diabetes Management Market estimates & forecasts, 2019-2029 (USD Billion)
  • TABLE 55. RoAPAC Artificial Intelligence (AI) in Diabetes Management Market estimates & forecasts by segment 2019-2029 (USD Billion)
  • TABLE 56. RoAPAC Artificial Intelligence (AI) in Diabetes Management Market estimates & forecasts by segment 2019-2029 (USD Billion)
  • TABLE 57. Brazil Artificial Intelligence (AI) in Diabetes Management Market estimates & forecasts, 2019-2029 (USD Billion)
  • TABLE 58. Brazil Artificial Intelligence (AI) in Diabetes Management Market estimates & forecasts by segment 2019-2029 (USD Billion)
  • TABLE 59. Brazil Artificial Intelligence (AI) in Diabetes Management Market estimates & forecasts by segment 2019-2029 (USD Billion)
  • TABLE 60. Mexico Artificial Intelligence (AI) in Diabetes Management Market estimates & forecasts, 2019-2029 (USD Billion)
  • TABLE 61. Mexico Artificial Intelligence (AI) in Diabetes Management Market estimates & forecasts by segment 2019-2029 (USD Billion)
  • TABLE 62. Mexico Artificial Intelligence (AI) in Diabetes Management Market estimates & forecasts by segment 2019-2029 (USD Billion)
  • TABLE 63. RoLA Artificial Intelligence (AI) in Diabetes Management Market estimates & forecasts, 2019-2029 (USD Billion)
  • TABLE 64. RoLA Artificial Intelligence (AI) in Diabetes Management Market estimates & forecasts by segment 2019-2029 (USD Billion)
  • TABLE 65. RoLA Artificial Intelligence (AI) in Diabetes Management Market estimates & forecasts by segment 2019-2029 (USD Billion)
  • TABLE 66. Row Artificial Intelligence (AI) in Diabetes Management Market estimates & forecasts, 2019-2029 (USD Billion)
  • TABLE 67. Row Artificial Intelligence (AI) in Diabetes Management Market estimates & forecasts by segment 2019-2029 (USD Billion)
  • TABLE 68. Row Artificial Intelligence (AI) in Diabetes Management Market estimates & forecasts by segment 2019-2029 (USD Billion)
  • TABLE 69. List of secondary sources, used in the study of global Artificial Intelligence (AI) in Diabetes Management Market
  • TABLE 70. List of primary sources, used in the study of global Artificial Intelligence (AI) in Diabetes Management Market
  • TABLE 71. Years considered for the study
  • TABLE 72. Exchange rates considered

List of tables and figures and dummy in nature, final lists may vary in the final deliverable

LIST OF FIGURES

List of figures

  • FIG 1. Global Artificial Intelligence (AI) in Diabetes Management Market, research methodology
  • FIG 2. Global Artificial Intelligence (AI) in Diabetes Management Market, Market estimation techniques
  • FIG 3. Global Market size estimates & forecast methods
  • FIG 4. Global Artificial Intelligence (AI) in Diabetes Management Market, key trends 2021
  • FIG 5. Global Artificial Intelligence (AI) in Diabetes Management Market, growth prospects 2022-2029
  • FIG 6. Global Artificial Intelligence (AI) in Diabetes Management Market, porters 5 force model
  • FIG 7. Global Artificial Intelligence (AI) in Diabetes Management Market, pest analysis
  • FIG 8. Global Artificial Intelligence (AI) in Diabetes Management Market, value chain analysis
  • FIG 9. Global Artificial Intelligence (AI) in Diabetes Management Market by segment, 2019 & 2029 (USD Billion)
  • FIG 10. Global Artificial Intelligence (AI) in Diabetes Management Market by segment, 2019 & 2029 (USD Billion)
  • FIG 11. Global Artificial Intelligence (AI) in Diabetes Management Market by segment, 2019 & 2029 (USD Billion)
  • FIG 12. Global Artificial Intelligence (AI) in Diabetes Management Market by segment, 2019 & 2029 (USD Billion)
  • FIG 13. Global Artificial Intelligence (AI) in Diabetes Management Market by segment, 2019 & 2029 (USD Billion)
  • FIG 14. Global Artificial Intelligence (AI) in Diabetes Management Market, regional snapshot 2019 & 2029
  • FIG 15. North America Artificial Intelligence (AI) in Diabetes Management Market 2019 & 2029 (USD Billion)
  • FIG 16. Europe Artificial Intelligence (AI) in Diabetes Management Market 2019 & 2029 (USD Billion)
  • FIG 17. Asia pacific Artificial Intelligence (AI) in Diabetes Management Market 2019 & 2029 (USD Billion)
  • FIG 18. Latin America Artificial Intelligence (AI) in Diabetes Management Market 2019 & 2029 (USD Billion)
  • FIG 19. Global Artificial Intelligence (AI) in Diabetes Management Market, company Market share analysis (2021)

List of tables and figures and dummy in nature, final lists may vary in the final deliverable